Community Engagement for Substance Use Disorder
(JCOIN II TCU Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The current study proposes to use a Hybrid Type 3 implementation research strategy to: 1) Significantly enhance our understanding of public health outcomes \[e.g., overdose incidents and substance-use (SU)-related Emergency Medical Service (EMS) contacts\] and public safety outcomes (e.g., drug-related arrests) associated with Deflection and Pre-Arrest Diversion initiatives (DPAD, hereafter referred to as Deflection); and 2) Create a lasting contribution to the fields of research focused on SU and the criminal legal system (CLS) by advancing knowledge of effective implementation strategies involving the critical role of community engagement in Deflection. The highly experienced team of Multiple PIs, senior-level collaborators from both Deflection and Community Behavioral Health (CBH), state-level evaluation partners, a national stakeholder advisory group, and CLS and behavioral health partners within each community have teamed up to carry out the proposed project. The study approach uses a hybrid implementation-effectiveness design to examine strategies to improve opioid and stimulant relevant outcomes, and specifically proposes to test the implementation-effectiveness of 2 strategy bundles to promote Deflection models through a CORE community engagement bundle (designed to facilitate community stakeholder engagement) and ENHANCED community engagement bundle (CORE plus a component to systematically involve community advocates) on improving implementation as well as public safety and health outcomes. The proposed randomized control trial includes a total of 20 geographically distinct clinical research performance sites (i.e., 20 communities spanning 5 states; New Mexico, Illinois, Wisconsin, Colorado, and Pennsylvania), with 3-5 communities per state and the inclusion of key CLS and CBH stakeholders within each site. The large scope of the project will maximize potential generalizability of study results and sustainability of implementation strategies.
Who Is on the Research Team?
Jennifer E Becan, Ph.D.
Principal Investigator
Texas Christian University
Kevin Knight, Ph.D.
Principal Investigator
Texas Christian University
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Implementation of CORE and ENHANCED community engagement bundles to promote Deflection models
Follow-up
Participants are monitored for changes in public health and safety collaboration, citizen awareness, and deflection workforce referrals
What Are the Treatments Tested in This Trial?
Interventions
- Core-interagency community engagement approach
- Enhanced-Core plus community engagement specialist
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
core plus strategic role development and coaching of known and trusted citizens to serve as Community Advocates in promoting community support of deflection efforts and fully engage in deflection leadership decisions
facilitated public health-public safety interagency collaboration, best practices on building community engagement, and cross-system data driven learning
Find a Clinic Near You
Who Is Running the Clinical Trial?
Texas Christian University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.